Literature DB >> 3514655

Tentative interpretive criteria for in vitro antibacterial susceptibility testing with imipenem.

D L Shungu, A T Cerami, E Weinberg, T Capizzi, H H Gadebusch.   

Abstract

Imipenem is a member of a new class of highly potent beta-lactam antibiotics, carbapenems, with a very broad antibacterial spectrum. This study was undertaken to determine tentative interpretive criteria for in vitro susceptibility testing with 10-micrograms imipenem disks. A careful examination of the zone diameters and the corresponding MICs for 489 clinical isolates by regression-line analysis and the error rate-bounded classification scheme suggested the following guidelines: greater than or equal to 16 mm with an MIC correlate of less than or equal to 4 micrograms/ml for susceptible, 14 to 15 mm (8 micrograms/ml) for moderately susceptible, and less than or equal to 13 mm (greater than or equal to 16 micrograms/ml) for resistant. Lack of cross-resistance between imipenem and broad-spectrum cephalosporins such as cefotaxime and ceftazidime argues against their use as class disks to predict in vitro susceptibility of bacterial species to carbapenems.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3514655      PMCID: PMC268666          DOI: 10.1128/jcm.23.3.421-424.1986

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  9 in total

1.  Susceptibility tests of anaerobic bacteria: statistical and clinical considerations.

Authors:  C M Metzler; R M DeHaan
Journal:  J Infect Dis       Date:  1974-12       Impact factor: 5.226

2.  Interpretive standards and quality control guidelines for imipenem susceptibility tests with 10-micrograms disks.

Authors:  A L Barry; C Thornsberry; T L Gavan; R N Jones
Journal:  J Clin Microbiol       Date:  1984-11       Impact factor: 5.948

3.  The plasma pharmacokinetics of high dose (1 g) imipenem coadministered with 1 g cilastatin in six normal volunteers.

Authors:  G L Drusano; H C Standiford; C I Bustamante; A Forrest; G Rivera; B Tatem; S C Schimpff
Journal:  Eur J Clin Microbiol       Date:  1984-10       Impact factor: 3.267

Review 4.  In vitro activity of imipenem--a review.

Authors:  I Braveny
Journal:  Eur J Clin Microbiol       Date:  1984-10       Impact factor: 3.267

5.  Urinary recovery of N-formimidoyl thienamycin (MK0787) as affected by coadministration of N-formimidoyl thienamycin dehydropeptidase inhibitors.

Authors:  S R Norrby; K Alestig; B Björnegård; L A Burman; F Ferber; J L Huber; K H Jones; F M Kahan; J S Kahan; H Kropp; M A Meisinger; J G Sundelof
Journal:  Antimicrob Agents Chemother       Date:  1983-02       Impact factor: 5.191

Review 6.  Thienamycin: development of imipenen-cilastatin.

Authors:  F M Kahan; H Kropp; J G Sundelof; J Birnbaum
Journal:  J Antimicrob Chemother       Date:  1983-12       Impact factor: 5.790

7.  Carbapenems, a new class of beta-lactam antibiotics. Discovery and development of imipenem/cilastatin.

Authors:  J Birnbaum; F M Kahan; H Kropp; J S MacDonald
Journal:  Am J Med       Date:  1985-06-07       Impact factor: 4.965

8.  Cefoperazone disk diffusion susceptibility test: confirmation of the tentative interpretive criteria, Pseudomonas aeruginosa cross-resistance, and determination of quality control performance limits.

Authors:  R N Jones; T L Gavan; A L Barry; C Thornsberry; D L Gibbs
Journal:  J Clin Microbiol       Date:  1982-05       Impact factor: 5.948

9.  In vitro activity of N-formimidoyl thienamycin in comparison with cefotaxime, moxalactam, and ceftazidime.

Authors:  L Verbist; J Verhaegen
Journal:  Antimicrob Agents Chemother       Date:  1981-03       Impact factor: 5.191

  9 in total
  4 in total

1.  Prediction of enterococcal imipenem susceptibility using ampicillin or penicillin MICs: more evidence for a class concept.

Authors:  R N Jones
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

2.  Comparative evaluation of penicillin, ampicillin, and imipenem MICs and susceptibility breakpoints for vancomycin-susceptible and vancomycin-resistant Enterococcus faecalis and Enterococcus faecium.

Authors:  M P Weinstein
Journal:  J Clin Microbiol       Date:  2001-07       Impact factor: 5.948

3.  Endophthalmitis caused by Enterococcus mundtii.

Authors:  Tomomi Higashide; Mami Takahashi; Akira Kobayashi; Shinji Ohkubo; Mayumi Sakurai; Yutaka Shirao; Toshihiro Tamura; Kazuhisa Sugiyama
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

4.  Multicenter evaluation of use of penicillin and ampicillin as surrogates for in vitro testing of susceptibility of enterococci to imipenem.

Authors:  Melvin P Weinstein; Stanley Mirrett; Saman Kannangara; Jan Monahan; Lizzie J Harrell; Alan C Wilson; L Barth Reller
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.